HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jun Hou Selected Research

Cleavage Stimulation Factor

1/2022Cleavage Stimulation Factor Subunit 2: Function Across Cancers and Potential Target for Chemotherapeutic Drugs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jun Hou Research Topics

Disease

62Neoplasms (Cancer)
11/2022 - 04/2009
22Infections
12/2020 - 03/2006
11Stomach Neoplasms (Stomach Cancer)
01/2020 - 08/2012
10Hepatocellular Carcinoma (Hepatoma)
11/2022 - 03/2012
10Neoplasm Metastasis (Metastasis)
04/2022 - 07/2009
10Fibrosis (Cirrhosis)
01/2019 - 01/2012
8Carcinoma (Carcinomatosis)
12/2019 - 12/2003
7Adenocarcinoma
01/2021 - 11/2008
6Traumatic Brain Injuries (Traumatic Brain Injury)
01/2022 - 12/2016
6Esophageal Squamous Cell Carcinoma
01/2022 - 08/2012
6Hepatitis
01/2017 - 03/2002
5Carcinogenesis
11/2022 - 01/2014
5Neuroinflammatory Diseases
01/2022 - 12/2016
5Hepatitis B
09/2016 - 03/2002
4Brain Injuries (Brain Injury)
01/2022 - 12/2016
4Wounds and Injuries (Trauma)
01/2022 - 01/2014
4Inflammation (Inflammations)
01/2022 - 03/2016
4Diabetic Cardiomyopathies
12/2021 - 09/2013
4Hypoxia (Hypoxemia)
12/2021 - 07/2006
4Renal Cell Carcinoma (Grawitz Tumor)
11/2021 - 02/2009
4Takayasu Arteritis (Arteritis, Takayasu's)
01/2021 - 04/2012
4Chronic Hepatitis B
01/2019 - 03/2006
4Lymphatic Metastasis
01/2016 - 06/2014
3Liver Neoplasms (Liver Cancer)
11/2022 - 01/2020
3Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2012
3Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 06/2015
3Esophageal Neoplasms (Esophageal Cancer)
12/2021 - 06/2002
3Disease Progression
01/2021 - 01/2014
3Chronic Hepatitis C
01/2016 - 11/2014
3Cytomegalovirus Infections (Inclusion Disease)
03/2013 - 01/2009
2Reperfusion Injury
12/2022 - 08/2012
2Brain Edema (Cerebral Edema)
01/2022 - 03/2013
2COVID-19
05/2021 - 01/2021
2Dermatomyositis (Dermatopolymyositis)
01/2021 - 01/2021
2Necrosis
01/2021 - 01/2020
2Circulating Neoplastic Cells
01/2021 - 12/2020
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 10/2020
2Liver Cirrhosis (Hepatic Cirrhosis)
12/2020 - 03/2006
2Prostatic Neoplasms (Prostate Cancer)
10/2020 - 01/2018
2Mouth Neoplasms (Oral Cancer)
07/2020 - 06/2015
2Hemorrhage
01/2019 - 01/2015

Drug/Important Bio-Agent (IBA)

15Biomarkers (Surrogate Marker)IBA
01/2022 - 04/2012
12Proteins (Proteins, Gene)FDA Link
08/2021 - 04/2010
7Biological ProductsIBA
01/2022 - 07/2009
7Messenger RNA (mRNA)IBA
08/2021 - 10/2010
7mangiferinIBA
08/2021 - 01/2012
7DNA (Deoxyribonucleic Acid)IBA
01/2021 - 03/2002
6Pharmaceutical PreparationsIBA
01/2022 - 01/2014
6EnzymesIBA
01/2021 - 03/2006
5Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
07/2022 - 11/2015
5RNA (Ribonucleic Acid)IBA
01/2022 - 05/2013
5Hepatitis B e AntigensIBA
01/2017 - 06/2004
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 01/2014
4InflammasomesIBA
01/2022 - 01/2014
4CytokinesIBA
01/2022 - 05/2016
4Interleukin-6 (Interleukin 6)IBA
01/2021 - 04/2012
4ParaffinIBA
10/2020 - 04/2010
4Oxaliplatin (Eloxatin)FDA LinkGeneric
06/2018 - 06/2014
4Capecitabine (Xeloda)FDA Link
06/2018 - 06/2014
4Streptozocin (Streptozotocin)FDA Link
03/2016 - 01/2012
3Long Noncoding RNAIBA
11/2022 - 01/2019
3Phosphotransferases (Kinase)IBA
01/2022 - 08/2009
3Methotrexate (Mexate)FDA LinkGeneric
12/2021 - 04/2002
3Hemoglobins (Hemoglobin)IBA
05/2021 - 05/2007
3Circular RNAIBA
02/2021 - 01/2018
3CollagenIBA
01/2021 - 09/2014
3Transcription Factors (Transcription Factor)IBA
01/2021 - 01/2019
3Trastuzumab (Herceptin)FDA Link
11/2019 - 08/2012
3InterferonsIBA
01/2019 - 11/2014
3XELOXIBA
06/2018 - 06/2014
3Antiviral Agents (Antivirals)IBA
11/2014 - 01/2009
3p38 Mitogen-Activated Protein KinasesIBA
09/2014 - 01/2012
2Indicators and Reagents (Reagents)IBA
11/2022 - 01/2020
2Cisplatin (Platino)FDA LinkGeneric
11/2022 - 01/2020
2Carcinoembryonic AntigenIBA
04/2022 - 06/2018
2Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2018
2Triglycerides (Triacylglycerol)IBA
01/2022 - 11/2018
2NLR ProteinsIBA
01/2022 - 12/2016
2LipidsIBA
01/2022 - 12/2016
2Prednisone (Sone)FDA LinkGeneric
12/2021 - 01/2021
2ChemokinesIBA
12/2021 - 08/2021
2MicroRNAs (MicroRNA)IBA
01/2021 - 10/2020
2Interleukin-10 (Interleukin 10)IBA
01/2021 - 08/2012
2HydrogelsIBA
01/2021 - 06/2019
2Sorafenib (BAY 43-9006)FDA Link
01/2021 - 12/2019
2Capsules (Microcapsules)IBA
01/2021 - 01/2019
2LipopolysaccharidesIBA
01/2021 - 07/2012
2Caspase 3 (Caspase-3)IBA
12/2020 - 01/2018
2Formaldehyde (Formol)FDA Link
10/2020 - 01/2020
2IronIBA
01/2020 - 01/2013
2Eosine Yellowish-(YS) (Eosin)IBA
12/2019 - 05/2016
2Hematoxylin (Haematoxylon)IBA
12/2019 - 05/2016

Therapy/Procedure

27Therapeutics
03/2021 - 01/2009
7Kidney Transplantation
01/2017 - 08/2008
6Drug Therapy (Chemotherapy)
08/2021 - 01/2012
5Neoadjuvant Therapy
04/2022 - 04/2009
4Adjuvant Chemotherapy
04/2022 - 02/2013
2Chinese Traditional Medicine (Traditional Chinese Medicine)
12/2022 - 01/2022
2Transcranial Direct Current Stimulation
01/2021 - 01/2020
2Precision Medicine
12/2019 - 02/2019